Matthew J. Arango

Gemcitabine‐Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine

T. Bekaii-Saab, S. Cataland, J. Reardon, 2017, Clinical colorectal cancer.

First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.

J. Reardon, L. Abushahin, Eric M McLaughlin, 2022, Future oncology.

Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience

A. Noonan, K. Porter, J. Reardon, 2019, Medical Oncology.

Department Annual Report: An Effective Tool for Advancing the Pharmacy Practice Model

R. Weber, Matthew J. Arango, 2012 .